Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study.

Paola Guglielmelli; Flavia Biamonte; Giada Rotunno; Valentina Artusi; Lucia Artuso; Isabella Bernardis; Elena Tenedini; Lisa Pieri; Chiara Paoli; Carmela Mannarelli; Rajmonda Fjerza; Elisa Rumi; Viktoriya Stalbovskaya; Matthew Squires; Mario Cazzola; Rossella Manfredini; Claire Harrison; Enrico Tagliafico; Alessandro M Vannucchi

doi:10.1182/blood-2013-11-536557

Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study.

Paola Guglielmelli, Flavia Biamonte, Giada Rotunno, Valentina Artusi, Lucia Artuso, Isabella Bernardis, Elena Tenedini, Lisa Pieri, Chiara Paoli, Carmela Mannarelli, Rajmonda Fjerza, Elisa Rumi, Viktoriya Stalbovskaya, Matthew Squires, Mario Cazzola, Rossella Manfredini, Claire Harrison, Enrico Tagliafico, Alessandro M Vannucchi

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

106 Citations (Web of Science)

Original language	English
Pages (from-to)	2157-2160
Journal	BLOOD
Volume	123
Issue number	14
DOIs	https://doi.org/10.1182/blood-2013-11-536557
Publication status	Published - 2014

Keywords

INTERNATIONAL WORKING GROUP
MYELOPROLIFERATIVE NEOPLASMS
AVAILABLE THERAPY
SURVIVAL
JAK2
EFFICACY
SAFETY

Access to Document

10.1182/blood-2013-11-536557

Cite this

Guglielmelli, P., Biamonte, F., Rotunno, G., Artusi, V., Artuso, L., Bernardis, I., Tenedini, E., Pieri, L., Paoli, C., Mannarelli, C., Fjerza, R., Rumi, E., Stalbovskaya, V., Squires, M., Cazzola, M., Manfredini, R., Harrison, C., Tagliafico, E., & Vannucchi, A. M. (2014). Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study. BLOOD , 123(14), 2157-2160. https://doi.org/10.1182/blood-2013-11-536557

Guglielmelli, Paola ; Biamonte, Flavia ; Rotunno, Giada et al. / Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study. In: BLOOD 2014 ; Vol. 123, No. 14. pp. 2157-2160.

@article{a04e3939dae84c12b414ba4240709895,

title = "Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study.",

keywords = "INTERNATIONAL WORKING GROUP, MYELOPROLIFERATIVE NEOPLASMS, AVAILABLE THERAPY, SURVIVAL, JAK2, EFFICACY, SAFETY",

author = "Paola Guglielmelli and Flavia Biamonte and Giada Rotunno and Valentina Artusi and Lucia Artuso and Isabella Bernardis and Elena Tenedini and Lisa Pieri and Chiara Paoli and Carmela Mannarelli and Rajmonda Fjerza and Elisa Rumi and Viktoriya Stalbovskaya and Matthew Squires and Mario Cazzola and Rossella Manfredini and Claire Harrison and Enrico Tagliafico and Vannucchi, \{Alessandro M\}",

year = "2014",

doi = "10.1182/blood-2013-11-536557",

language = "English",

volume = "123",

pages = "2157--2160",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

number = "14",

}

Guglielmelli, P, Biamonte, F, Rotunno, G, Artusi, V, Artuso, L, Bernardis, I, Tenedini, E, Pieri, L, Paoli, C, Mannarelli, C, Fjerza, R, Rumi, E, Stalbovskaya, V, Squires, M, Cazzola, M, Manfredini, R, Harrison, C, Tagliafico, E & Vannucchi, AM 2014, 'Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study.', BLOOD , vol. 123, no. 14, pp. 2157-2160. https://doi.org/10.1182/blood-2013-11-536557

Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study. / Guglielmelli, Paola; Biamonte, Flavia; Rotunno, Giada et al.
In: BLOOD , Vol. 123, No. 14, 2014, p. 2157-2160.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study.

AU - Guglielmelli, Paola

AU - Biamonte, Flavia

AU - Rotunno, Giada

AU - Artusi, Valentina

AU - Artuso, Lucia

AU - Bernardis, Isabella

AU - Tenedini, Elena

AU - Pieri, Lisa

AU - Paoli, Chiara

AU - Mannarelli, Carmela

AU - Fjerza, Rajmonda

AU - Rumi, Elisa

AU - Stalbovskaya, Viktoriya

AU - Squires, Matthew

AU - Cazzola, Mario

AU - Manfredini, Rossella

AU - Harrison, Claire

AU - Tagliafico, Enrico

AU - Vannucchi, Alessandro M

PY - 2014

Y1 - 2014

KW - INTERNATIONAL WORKING GROUP

KW - MYELOPROLIFERATIVE NEOPLASMS

KW - AVAILABLE THERAPY

KW - SURVIVAL

KW - JAK2

KW - EFFICACY

KW - SAFETY

U2 - 10.1182/blood-2013-11-536557

DO - 10.1182/blood-2013-11-536557

M3 - Original Article

C2 - 24458439

SN - 0006-4971

VL - 123

SP - 2157

EP - 2160

JO - BLOOD

JF - BLOOD

IS - 14

ER -

Guglielmelli P, Biamonte F, Rotunno G, Artusi V, Artuso L, Bernardis I et al. Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study. BLOOD . 2014;123(14):2157-2160. doi: 10.1182/blood-2013-11-536557